Introduction {#s1}
============

Since the positive laboratory test result of "patient 1" in Codogno, Italy, on 21 February 2020, Italian medical health personnel have been fighting the COVID-19 disease caused by a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In the past two decades, two other coronaviruses switched hosts into humans; SARS-CoV in the Guangdong province (China), finally contained on 5 July 2003, and Middle East Respiratory Syndrome coronavirus, which has caused around 2500 cases since September 2012 \[[@C1]\]. The SARS and Middle East Respiratory Syndrome outbreaks were characterised by the so-called "super spreading events", often occurring in hospitals \[[@C2]\].

There are currently official recommendations available on this topic from the World Health Organization (WHO) and national/international scientific societies \[[@C3]--[@C6]\]. The aim of this article is not only to summarise some of the official recommendations (*i.e.* WHO, European of Centre of Disease Prevention and Control and the Italian Department of Health), but also to provide a comparison between them.

How can we minimise contagion among healthcare professionals, what are the measures to take and what are the methods of ventilatory support at lower risk of contamination? {#s2}
===========================================================================================================================================================================

This article tries to answer these fundamental questions through a diversified approach.

Accordingly, this document is divided into three parts, as follows. 1) Risk of transmission during oxygen administration/high flow nasal cannula (HFNC) oxygen therapy, continuous positive airway pressure (CPAP) and noninvasive ventilation (NIV). 2) Safety measures to minimise COVID-19 transmission through contact/droplets. 3) Precautions to minimise transmission in the case of aerosol-generating procedures in COVID-19 patients.

1.. Risk of transmission during oxygen administration *via* nasal cannula/HFNC/CPAP/NIV {#s2a}
---------------------------------------------------------------------------------------

The risk of transmission of respiratory infections for healthcare workers depends on several conditions; some of them are nonspecific such as prolonged exposure, inadequate hand hygiene and personal protective equipment (PPE), insufficient spacing or rooms without negative pressure or insufficient air changes every hour \[[@C7]\]. In healthcare workers\' clinical practice, another important variable to consider is the exhaled air dispersion distance during oxygen administration and ventilatory support.

All data relating to exhaled air dispersion during such procedures come from scientific studies conducted in a negative pressure room, on a high-fidelity human patient simulator (HPS) that represents a 70 kg adult male sitting on a 45° inclined hospital bed. Exhaled air dispersion distance from the HPS has been evaluated using a laser smoke visualisation method and calculated on the median sagittal plane. [Table 1](#TB1){ref-type="table"} shows the maximum dispersion distances, the medium values are as follows. **Oxygen therapy *via* nasal cannula**: exhaled air spreads from the HPS\'s nostrils towards the end of the bed almost horizontally to 66 cm when the oxygen flow setting is 1 L·min^−1^, to 70 cm when it is increased to 3 L·min^−1^ and 1 m when it is 3--5 L·min^−1^ \[[@C8]\].**Oxygen therapy *via* oronasal masks**: the exhaled air jet reaches 40 cm with an oxygen flow of 4 L·min^−1^ \[[@C9]\].**Oxygen therapy *via* Venturi mask:** exhaled air dispersion distance reduces with increasing lung injury. Delivering 24% oxygen with a flow rate at 4 L·min^−1^ in a normal lung and severe lung injury setting produces an air dispersion of 40 cm and 32 cm, respectively. When 40% oxygen is delivered at an 8 L·min^−1^ flow rate the exhaled air dispersion distance is, in the same two lung settings, 33 cm and 29 cm, respectively \[[@C10]\]. These distances were studied in a general ward without negative pressure, but with double exhaust fans for room ventilation. When they were off, the air ventilation rates on the ward dropped significantly and the exhaled smoke filled the ward within 5 min.**Oxygen therapy *via* non-rebreathing mask**: exhaled air dispersion distance is \<10 cm irrespective of oxygen flow rate (6--8--10--12 L·min^−1^) in either normal lung or severe lung injury \[[@C6]\].**CPAP *via* oronasal mask**: (CPAP 5, 10, 15 or 20 cmH~2~O) exhaled air disperses evenly in all directions through the mask\'s vent holes at a very low normalised smoke concentration irrespective of the severity of lung injury \[[@C11]\] and, therefore, it was not feasible to measure distinct exhaled air dispersion.**CPAP *via* nasal cannula (nasal pillows)**: there is an increase of air dispersion with increasing CPAP and a reduction of air dispersion with worsening lung injury. Using two types of nasal pillows, at a maximum CPAP of 20 cmH~2~O and with a normal lung, maximum air dispersion distances are 26.4 cm (Nuance Pro Gel) and 33.2 cm (Swift FX) \[[@C11]\].**HFNC**: in a normal lung, there is an increase of air dispersion distance with increasing flow to a maximum of 17.2 cm at 60 L·min^−1^. With this flow rate, when nasal cannula is tightly connected lateral air dispersion is negligible, otherwise it can reach 62 cm. Worsening lung injury causes a reduction in air dispersion distance from HPS \[[@C11]\].**NIV *via* full-face mask**: in the Bilevel setting (inspiratory positive airway pressure (IPAP) 10 cmH~2~O and expiratory positive airway pressure (EPAP) 5 cmH~2~O) with a single limb circuit connected to HPS, the exhaled air jet spreads through the mask\'s holes up to 69.3 cm, 61.8 cm and 58 cm in the normal lung, mild lung injury and severe lung injury setting, respectively. Increasing IPAP leads to increasing exhaled air dispersion distance, *e.g.* with IPAP 18 cmH~2~O exhaled air jet reaches 91.6 cm \[[@C12]\].**NIV *via* helmets**: with IPAP 12 cmH~2~O and EPAP 10 cmH~2~O, the exhaled air dispersion distance is 17 cm in normal lung and 15 cm in mild or severe lung injury. With IPAP 20 cmH~2~O the air dispersion distances in three different settings (normal lung, mild lung injury and severe lung injury) are 27, 23 and 18 cm, respectively (*e.g.* Oxygen Head Tent; Sea-Long, Waxahachie, TX, USA). Helmets with a tight air cushion around the neck--helmet interface, in a double limb circuit, have negligible air dispersion during NIV application (*e.g.* CaStar R; StarMed, Wokingham, UK) \[[@C12]\].

###### 

Maximum exhaled air dispersion distance *via* different oxygen administration and ventilatory support strategies

  **Method**                                                                              **Maximum exhaled air dispersion distance**
  ---------------------------------------------------------------------------------- -----------------------------------------------------
  **Oxygen *via* nasal cannula 5 L·min^−1^**                                                                100 cm
  **Oxygen *via* oronasal mask 4 L·min^−1^**                                                                 40 cm
  **Oxygen *via* Venturi mask *F*~IO~2~~** **40%**                                                           33 cm
  **Oxygen *via* non-rebreathing mask 12 L·min^−1^**                                                        \<10 cm
  **CPAP *via* oronasal mask 20 cmH~2~O**                                                          Negligible air dispersion
  **CPAP *via* nasal pillows**                                                                               33 cm
  **HFNC 60 L·min^−1^**                                                               17 cm (62 cm sideways leakage if not tightly fixed)
  **NIV *via* full face mask: IPAP 18 cmH~2~O, EPAP 5 cmH~2~O**                                              92 cm
  **NIV *via* helmet without tight air cushion: IPAP 20 cmH~2~O, EPAP 10 cmH~2~O**                           27 cm
  **NIV *via* helmet with tight air cushion: IPAP 20 cmH~2~O, EPAP 10 cmH~2~O**                    Negligible air dispersion

*F*~IO~2~~: inspiratory oxygen fraction; CPAP: continuous positive airway pressure; HFNC: high-flow nasal canula; NIV: noninvasive ventilation; IPAP: inspiratory positive airway pressure; EPAP: expiratory positive airway pressure.

Nebulisation of drugs with the jet nebuliser causes sideways leakage of exhaled air and the distance increases with increasing lung injury. Dispersion distance is: 45 cm in the normal lung setting (oxygen consumption 200 mL·min^−1^, lung compliance 70 mL·cm^−1^ H~2~O); 54 cm in mild lung injury (oxygen consumption 300 mL·min^−1^, lung compliance 35 mL·cm^−1^ H~2~O); and 80 cm in severe lung injury (oxygen consumption 500 mL·min^−1^, lung compliance 10 mL·cm^−1^ H~2~O) \[[@C10]\].

Coughing, without wearing a mask, produces an exhaled air jet on a median sagittal plane of 68 cm from HPS (the patient); wearing a surgical mask reduces this distance to 30 cm, while wearing a N95 mask the distance was reduced to 15 cm. It is necessary to be aware that wearing a mask does not prevent air leakage between the mask and the skin; air dispersion distance is 28 cm with a surgical mask and 15 cm with a N95 mask \[[@C13]\].

Thus, we can state that CPAP *via* an oronasal mask and NIV *via* a helmet equipped with an inflatable neck cushion are the ventilatory support methods that allow the minimum room air contamination. However, we can argue that pressures set during NIV *via* helmet ventilation are relatively low. Moreover, all examined studies used smoke as the air exhaled marker, while viral transmission seems to happen through droplets; droplets are, indeed, heavier thus they should follow a briefer trajectory than the smoke. All results shown should, therefore, represent the upper limit of exhaled air dispersion and thus overestimate it. It\'s interesting to note, however, that all studies (except the one that used a Venturi mask) were conducted in a negative pressure room with at least six air changes per hour (minimum air changes recommended by WHO is 12 per hour) \[[@C4], [@C14]\]. In medical wards not equipped with negative pressure rooms, like those which admit most COVID-19 patients because of reduced bed availability, it is reasonable to imagine a higher exhaled air dispersion and contamination.

2.. Safety measure to minimise COVID-19 transmission through contact/droplets {#s2b}
-----------------------------------------------------------------------------

Exhaled aerosol size depends on the characteristics of the fluid, the force and pressure at the moment of emission, and environmental conditions (*e.g.* temperature, relative humidity and air flow). Large size particles remain suspended in the air for a short period and settle within 1 m from the source. Smaller particles evaporate rapidly, while dry residues slowly settle and remain suspended for a variable amount of time. Infectious respiratory aerosols are as follows. 1) Droplets: respiratory aerosol \>5 µm diameter; 2) droplets nuclei: dry part of the aerosol (\<5 µm diameter) which results from the evaporation of coughed or sneezed droplets or from exhaled infectious particles \[[@C14]\]. According to the available evidence, SARS-CoV-2 transmission occurs through droplets.

### Preventive measurements for patients, healthcare workers and community {#s2b1}

-   Wash your hands often with an alcohol-based (\>65%) detergent if your hands are not apparently dirty, with soap and water if they are contaminated. Always wash your hands after contact with respiratory secretions

-   Avoid contact with eyes, nose and mouth

-   Sneeze and cough into a bent elbow or tissue and then throw it away

-   Wear a surgical mask if respiratory symptoms appear and immediately afterwards wash your hands

-   Keep a distance of at least 1 m from patients with respiratory symptoms

### Prevention and control of suspected COVID-19 syndrome {#s2b2}

#### Patient placement {#s2b2a}

Patients should be placed in isolation rooms with negative pressure (at least 12 air changes per hour) a dedicated bathroom and, if possible, an anteroom. If negative pressure rooms are not available, choose rooms with natural ventilation with airflow of at least 160 L·s^−1^ per patient \[[@C4]\]. If single rooms are not accessible, patients with suspected SARS-CoV-2 infection should be placed in the same room. Patients\' beds should be located at least 1 m away from each other. It is critical that the area prepared to receive suspect patients is equipped with all the necessary PPE. All patients should wear a medical mask. It is critical to limit the number of healthcare professionals in contact with confirmed or suspected cases of COVID-19. It is better to put together a team of healthcare professionals who deal exclusively with suspected or confirmed cases to minimise the risk of transmission. A reminder to all the people who enter the patient\'s room is recommended, including healthcare workers and family members.

### PPE {#s2b3}

#### Masks and respirators {#s2b3a}

Fabric masks (cotton or gauze) should not be used and are not recommended in any circumstance. Medical or surgical masks could be flat or plated (some are cup-shaped) and suitable for covering the nose and mouth. Secure them to the head with elastics or laces. These devices are made to guarantee one-way protection for healthcare workers, in order to capture their droplets. Respirators are tight masks that must seal off the wearer\'s face and work in a bidirectional sense, in particular for the protection of the wearer (*e.g.* from dust or fibres present in the air). The American system classifies ventilators according to the percentage of particles with a diameter \>0.3 µm that can be filtered by the masks themselves, while the European system distinguishes them according to the FFP1/2/3 classification. The N95 mask according to the American classification system is able to remove 95% of all particles with a diameter \>0.3 µm and it is comparable to a FFP2 mask according to the European classification system ([table 2](#TB2){ref-type="table"}) \[[@C15]\].

###### 

Respirator filtration efficiency according to the American and European classifications

  **Type of mask**                      **Filtration efficiency %**
  ------------------------------------ -----------------------------
  **American classification system**   
   N95                                              ≥95
   N99                                              ≥99
  **European classification system**   
   FFP1                                             ≥80
   FFP2                                             ≥94
   FFP3                                             ≥99

#### How to properly wear FFP2 and FFP3 masks {#s2b3b}

-   Carefully place the mask on the face and cover the nose and mouth to minimise the space between the face and mask;

-   While using the mask avoid touching it with your hands

-   Remove the mask using the appropriate technique (avoid contact with the front of the mask, remove the lace from behind)

-   After removal or when inadvertently touching a used mask, clean your hands using an alcohol-based cleaner or wash your hands using soap and water if visibly soiled

-   Throw the disposable masks away after each use in a closed bag and dispose of them immediately after removal \[[@C16]\]

The WHO advises healthcare workers to keep the same mask (FFP2 or higher) while routine care is being performed on multiple patients who have the same diagnosis, in order to rationalise the use of PPE and avoid an early depletion of stocks. Evidence indicates that FFP2/3 maintain their protection even when they are used for a long time. However, wearing a respirator for \>4 h can cause discomfort and should be avoided \[[@C3]\]. Masks and respirators are important PPE for protection against SARS-COV-2, but alone are not enough.

### Other PPE {#s2b4}

Correct PPE depends on the specific activity and healthcare setting. [Table 3](#TB3){ref-type="table"} shows which devices should be used based on the activity and contact with the patient \[[@C3]\]. Healthcare workers must wear a FFP2 mask, goggles or face shield, a long-sleeved water-resistant gown and gloves. If water-resistant gowns are not available, single-use plastic aprons should be worn over the gowns to avoid body contamination. After the patient\'s examination, PPE must be properly stripped and disposed of. Healthcare workers should avoid contact with the eyes and nose *via* potentially contaminated gloves or bare hands.

###### 

Recommended type of personal protective equipment (PPE) in the context of COVID-19 disease

  **Setting**                                                    **Target staff**                                                        **Activity**                               **Type of PPE/procedure**
  -------------------------------------------------------------- ----------------------------------------------------------------------- ------------------------------------------ -----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **COVID-19 patient room**                                      Healthcare workers                                                      Providing direct care                      FFP2 mask^\#^
  Double non-sterile gloves                                                                                                                                                         
  Long-sleeved water-resistant gown                                                                                                                                                 
  Goggles or face shield                                                                                                                                                            
  Aerosol-generating procedures performed on COVID-19 patients   FFP3 mask                                                                                                          
  Double non-sterile gloves                                                                                                                                                         
  Long-sleeved water-resistant gown                                                                                                                                                 
  Goggles or face shield                                                                                                                                                            
  Cleaners                                                       Entering the room of COVID-19 patients                                  FFP2 mask^\#^                              
  Heavy duty gloves                                                                                                                                                                 
  Gown                                                                                                                                                                              
  Goggles or face shield                                                                                                                                                            
  Boots or closed work shoes                                                                                                                                                        
  Visitors                                                       Visitors to COVID-19 patients are not allowed in Italy                                                             
  **Ambulance or transfer vehicle COVID-19 patient**             Healthcare workers                                                      Transporting suspected COVID-19 patients   FFP2 mask^\#^
  Double non-sterile gloves                                                                                                                                                         
  Long-sleeved water-resistant gown                                                                                                                                                 
  Goggles or face shield                                                                                                                                                            
  **Outpatient facilities**                                      Healthcare workers                                                      Patient with respiratory symptom           Medical mask
  Gloves                                                                                                                                                                            
  Disposable gown                                                                                                                                                                   
  Face shield                                                                                                                                                                       
  Patient without respiratory symptom                            Not indicated                                                                                                      
  Cleaners                                                       After and between consultations of patients with respiratory symptoms   Medical mask                               
  Heavy duty gloves                                                                                                                                                                 
  Gown                                                                                                                                                                              
  Goggles or face shield                                                                                                                                                            
  Boots or closed work shoes                                                                                                                                                        
  **Waiting room**                                               Patient                                                                                                            Patients with respiratory symptoms must wear a medical mask. If possible isolate patients with respiratory symptoms, otherwise keep a distance of 1 m from each other

While the World Health Organization (WHO) suggests wearing a surgical mask except in aerosol generating procedures, both the European Centre for Disease Prevention and Control report \[5\] and Italian Health Department \[6\] suggest the use of a FFP2 mask in case of suspected/confirmed COVID-19 and FFP3 in aerosol generating procedures. ^\#^: WHO suggest the use of a medical mask instead of FFP2. Reproduced with modification from \[3\] with permission from WHO.

[Table 4](#TB4){ref-type="table"} further illustrates the European of Centre of Disease Prevention recommendations for the protection of healthcare workers \[[@C5]\].

###### 

Minimum components of personal protective equipment (PPE) to prevent infections in confirmed or suspected case of COVID-19

  **Protection**               **Suggested PPE**
  ---------------------------- -----------------------------------
  **Respiratory protection**   FFP2 or FFP3 respirator
  **Eye protection**           Goggles or face shield
  **Body protection**          Long-sleeved water-resistant gown
  **Hand protection**          Gloves

It is also suggested to use a: FFP3 respirator when performing an aerosol-generating procedure; single-use plastic apron on top of the non-water-resistant gowns if long-sleeved water-resistant gowns are not available; and goggles that fit the contours of the user\'s face and are compatible with the respirator. Reproduced from \[5\] with permission of the ECDC.

A recent WHO document illustrates the correct dressing and undressing procedure, while a recent Italian Department of Health indication also summarises the dressing and undressing procedure ([table 5](#TB5){ref-type="table"}) \[[@C6]\]. During the undressing procedure, it is crucial to avoid contact with potentially contaminated PPE, face, skin and mucosa. It is important to dispose of single-use PPE in the undressing area.

###### 

Sequence of dressing and undressing actions for healthcare personnel in case of contact with suspected or confirmed case of COVID-19

  **Dressing procedure**                                            **Undressing procedure**
  ----------------------------------------------------------------- ----------------------------------------------------------------------------------
  Remove all jewellery and personal items                           Remove the disposable gown and dispose of it
  Practice hand hygiene with soap and water or alcoholic solution   Remove the first pair of gloves and dispose of them
  Check device integrity, do not use damaged devices                Remove the glasses and sanitise them
  Wear a first pair of gloves                                       Remove FFP2/FFP3 by handling it from the rear and dispose of it in the container
  Wear the disposable gown over the uniform                         Remove the second pair of gloves
  Wear FFP2/FFP3                                                    Practice hand hygiene with alcoholic solutions or with soap and water
  Wear protective glasses                                           
  Put on a second pair of gloves                                    

Data from \[6\].

Medical devices must be disposable or dedicated to a single patient (stethoscope, sphygmomanometer and thermometers). If these devices are used on different patients, they must be washed and disinfected after visiting each patient (using 70% ethyl alcohol). Clean and disinfect the surfaces with which patients come into contact.

Moving or transporting patients outside their room or dedicated area should be avoided if not necessary. Use portable X-ray machines or bedside chest ultrasound. If it is necessary to transport the patient, use pre-established preferential routes to minimise the exposure of healthcare professionals and other patients, by making the latter wear a mask. Make sure that transport personnel follow standard precautions and wear PPE \[[@C17]\].

### Optimising the availability of PPE {#s2b5}

Considering the global shortage of PPE, the following strategies can guarantee greater availability of PPE. Using PPE appropriately allows us to preserve it for situations of real transmission risk. Therefore, it is necessary to select the appropriate PPE and learn the right way to wear, remove and dispose of them properly. Strategies for optimising PPE include the following. Telemedicine to evaluate suspected cases of COVID-19 (*e.g.* toll-free numbers available in Italy)Use physical barriers to reduce exposure to the COVID-19 virus such as glass or plastic windows; this approach could be implemented in triage proceduresLimit the number of healthcare workers in patients\' rooms if they are not directly involved in patient care. Schedule all the activities in order to reduce the number of times entering the patients\' rooms (*e.g.* check vital signs when administering drugs or leaving food while performing other routine activities) and plan which activities should be carried out at the patient\'s bed \[[@C3]\]

3.. Precautions to minimise transmission in case of aerosol-generating procedures in COVID-19 patients {#s2c}
------------------------------------------------------------------------------------------------------

Aerosol-generating procedures expose healthcare workers at high risk of contagion \[[@C7]\]. Aerosol-generating procedures include airway suction, bronchoscopy, endotracheal intubation, tracheostomy and cardiopulmonary resuscitation. In a recent publication, the WHO also includes NIV \[[@C3]\]. Whenever possible, these procedures should be performed, in negative pressure rooms with a minimum of 12 air changes per hour or at least 160 L·s^−1^ per patient in facilities with natural ventilation, according to WHO guidelines \[[@C4]\].

Healthcare workers performing aerosol-generating procedures should wear a waterproof long-sleeved gown, double non-sterile gloves, eye protection (with lateral protection) and a respirator that ensures a level of protection equal or greater than N95/FFP2 ([table 2](#TB2){ref-type="table"}). The document issued by the European Centre for Disease Prevention and Control suggests a FFP3 mask for aerosol-generating procedures ([table 3](#TB3){ref-type="table"}) \[[@C5]\].

The practical recommendations for critical care and anaesthesiology teams released by a group of Canadian anaesthesiologists \[[@C18]\] also suggest the following additional measures for endotracheal intubation. Prioritise a planned early intubation rather than an emergency intubation, at high risk of contagionIf possible, avoid bag-mask ventilationEnsure adequate patient sedationMinimise the number of healthcare workers in the room to essential team membersProvide all necessary equipment and medication in the room, do not use the crash trolleyThis document also suggests wearing a shield visor in addition to protective goggles in order to guarantee double protection. Canadian anaesthesiologists\' advice to consider the use of powered air purifying respirators (PAPRs) for high-risk procedures ([figure 1](#F1){ref-type="fig"}). PAPRs use a battery-powered fan to conduct air through a filter allowing the wearer to breathe through a mask or a helmet. PAPRs may offer greater protection than FFP2, even if there is no evidence about comparison of these PPEs in terms of viral transmission. However, the use of PAPRs is burdened by the high costs and communication limits determined by the noise of the fan. Another risk that must be considered is the high probability of contamination during the undressing procedures, which makes it necessary to support healthcare workers with expert staff.

![Example of a powered air purifying respirator.](ERR-0068-2020.01){#F1}

More specific precautions are provided by the Chinese Thoracic Society \[[@C19]\], which gives further suggestions for the treatment and ventilatory support of COVID-19 patients. Do not use humidifiers during conventional oxygen therapyThe patient has to wear the surgical mask to reduce contamination risk of the roomDuring HFNC treatment, ensure correct placement of the nasal cannulas (which must be completely inserted in the nostrils and secured with the elastic bands on the patient\'s head in order to minimise lateral losses). Place a surgical mask over the nasal cannulas ([figure 2](#F2){ref-type="fig"})During NIV support, use a double-limb circuit with a non-vented mask. Place three filters per ventilator: between the expiratory port and the ventilator; between the inspiratory port and the ventilator; and another filter near the patient\'s mask. The interface with the lowest risk of aerosol emission is the helmet equipped with an inflatable neck cushionIf bag-mask ventilation is needed, place a filter between the bag valve and the mask/endotracheal tube to reduce airborne contaminationUse closed circuits in case suction is neededUse PPE during bronchoscopyEnsure the patient wears a cap that also covers the eyes in order to reduce the risk of face contamination (with eye discharge) during bronchoscopy. Place a suction catheter in the patient\'s oral cavity to ensure a local negative pressure that reduces the droplets released by the patient. Cover the patient\'s mouth with a mask. The suction circuit must be closed. If patient is supported by NIV, use the access through the hole on the patient\'s maskA shower is recommended after undressing, including disinfection of the ears and mouth

![Correct placement of high-flow nasal cannulas. On the left, correct placement of the cannulas. Nasal cannulas must be completely inserted into the nostrils, the elastic bands must be well secured to the patient\'s head, it is recommended to avoid folding of the tube near the interface. On the right, placement of a medical mask over the high-flow nasal cannulas. Modified from \[[@C19], [@C20]\].](ERR-0068-2020.02){#F2}

![Placement of the filter during bag-mask ventilation. Modified from \[[@C19]\].](ERR-0068-2020.03){#F3}

![Precautions provided by the Chinese Thoracic Society for bronchoscopy. Ensure the patient wears a cap that also covers the eyes, place a suction catheter in the patient\'s oral cavity and cover the patient\'s mouth with a surgical mask. Modified from \[[@C19]\].](ERR-0068-2020.04){#F4}

![Precautions provided by the Chinese Thoracic Society for bronchoscopy during noninvasive/invasive mechanical ventilation. Use the access port in the patient\'s mask/the mount. Modified from \[[@C19], [@C20]\].](ERR-0068-2020.05){#F5}

Conclusions {#s3}
===========

According to evidence, approximately 20% of COVID-19 patients develop a severe or critical form of disease (Adult Respiratory Distress Syndrome), which in 19--32% of cases requires respiratory support treatment \[[@C20]\]. Oxygen therapy, HFNC, CPAP and NIV are noninvasive support methods with a high risk of aerosol dispersion, especially in unprotected environments. Being aware of the exhalation distance of the various methods allows us to favour those with the lowest risk (*e.g.* helmet with an inflatable neck cushion) and to take the necessary precautions (*e.g.* correct placing of the HFNC). Despite the high risk of contagion during these procedures, evidence suggests that the observance of the indications for the use of PPE are effective in preventing infections among healthcare workers. In a case--control study conducted during the SARS epidemic in Hong Kong \[[@C21]\] which investigated the effective adhesion of personnel to PPE (gloves, disposable shirts, goggles and masks) none of the staff reporting use of all measures contracted the virus, while all the infected staff had omitted at least one measure. Given the high risk of emission of large quantities of droplets, aerosol-generating procedures require greater precaution by healthcare personnel.
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